Table: Fuji Pharmaceutical -2023/24 group results

Fuji Pharma

12/11/2024 07:02

Nov 12 (Reuters)- 
          Fuji Pharmaceutical  Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Sep 30, 2024    Sep 30, 2023   Sep 30, 2025     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           46.14           40.89          53.36        26.15    
               (+12.8 pct)     (+15.4 pct)    (+15.7 pct)  (+22.3 pct) 
  Operating        3.88            3.86           4.85         2.38    
               (+0.6 pct)      (+2.1 pct)     (+25.0 pct)  (+64.8 pct) 
  Recurring        4.45            4.52           4.68         2.33    
               (-1.6 pct)      (+21.3 pct)    (+5.3 pct)    (+7.6 pct) 
  Net
  Net              6.15            3.44           3.38         1.65    
               (+78.9 pct)     (+27.4 pct)    (-45.0 pct)  (-61.2 pct) 
  EPS          252.85 yen      141.37 yen     139.07 yen    67.91 yen  
  Ann Div       42.50 yen       37.00 yen      45.50 yen               
  -Q2 Div       20.00 yen       17.00 yen      20.00 yen               
  -Q4 Div       22.50 yen       20.00 yen      25.50 yen               
  
  NOTE - Fuji Pharmaceutical  Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T